#therapies
Collection of therapies news, found 184 news.
- S1P1 LEAD COMPOUNDS, AMG 369 AND AMG 277, WILL BE OFFERED FOR SALE AT A DECEMBER 8, 2011 ...
Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w
- In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...
Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido
-Analysis evaluated efficacy and safety among three patient sub-groups A new ...
Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
- Eli Lilly India (Lilly) and Lupin Limited (Lupin) today announced they have entered into a ...
- - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...
- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...
- Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...
Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...
Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
- Results of a new analysis from the largest-ever morbi-mortality study of ...
- Platelet Function Testing May Be Used to Aid Patient Management Accumetrics, ...
Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...